Gallery

Foundation Stone Ceremony

Foundation Stone for Mammalian Facility

Foundation stone of Gennova’s next generation multi-product mammalian bio-manufacturing facility was laid by Professor Govindarajan Padmanaban, former director of the Indian Institute of Science (IISc), Bangalore. This facility is named after Gennova’s former board member Late Professor Krishna Kumar Tewari, who inspired generation of scientist towards excellence.

Professor Tewari was the founding director of the International Centre for Genetic Engineering and Biotechnology (ICGEB)’s Indian unit. Professor Tewari held a faculty appointment in the School of Bioscience at the University of Irvine, USA where he served as Chair of the Department of Molecular Biology and Biochemistry from 1979 until 1994. Apart from being an honored scientist he was a man with a vision for science, an excellent human being and a caring mentor.

This facility is supported under National Biopharma Mission (NBM) of the Department of Biotechnology, Govt. of India.

Mr. Satish Mehta, Chairman of Gennova Biopharmaceuticals Ltd., welcoming dignitaries including the chief –guest Padmabhushan Prof. G. Padmanabhan, former director of the Indian Institute of Science (IISc), Bangalore and addressing the gathering in his welcome speech.

Dr. Sanjay Singh, CEO Gennova Biopharmaceuticals Ltd., introduced Gennova’s next-generation mammalian bio-manufacturing technology.

Padmabhushan Prof. G Padmanabhan, reflected on the life and work of Gennova’s former board member, Late Professor Krishna Kumar Tewari, who inspired generations of scientist towards excellence.

Dr. Renu Swaroop, Secretary, Department of Biotechnology, Govt. of India joined via video conference, addressing the audience on the vision of DBT and role of Gennova in the field of biopharmaceuticals.

The foundation stone was inaugurated by Padmabhushan Prof. G. Padmanabhan in presence of Mr. Satish Mehta.

Dr. Kavita Singh, Mission Director, National Biopharma Mission (NBM) of Department of Biotechnology. Govt. of India graced the occasion with her team. This project is supported under the National Biopharma Mission.

Dr. Sanjay Singh explaining the proposed infrastructure to the dignitaries

Post-inauguration, the employees of Gennova Biopharmaceuticals from various departments marked this moment of pride.

Global Bio

Gennova Biopharmaceuticals at Global Bio 2019

Gennova Biopharmaceuticals Ltd. participated in Global BIO India, 2019 held in New Delhi where Gennova’s website was launched by Honourable Minister of Health and Family Welfare, Dr. Harsh Vardhan in presence of Dr. Renu Swarup, Secretary, Department of Biotechnology (DBT), Mr. Ranjit Jabbi, Director – Confederation of Indian Industries (CII) among other dignitaries.

During a 3-day event Gennova was awarded the ‘DBT-Biotech Product, Process Development and Commercialization award 2019 (under Organization category)’ for development of Tenectase, a 3^rd generation thrombolytic glycoprotein for acute ischemic stroke (AIS) by the Honourable Minister of Railways and Minister of Commerce and Industry – Shri Piyush Goyal.

Gennova Bipharmaceuticals Ltd., at Global Bio-India 2019. Aerocity, New Delhi, India.

1-3-Assets-for-Gallery_Resized_747x527px-04-300x212

Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd. with Dr. Harsh Vardhan, Honorable Minister of Health and Family Welfare at the Gennova Stall.

3-1-Assets-for-Gallery_Resized_747x527px-02

Gennova’s website was inaugurated by Dr. Harsh Vardhan, Honorable Minister of Health and Family Welfare.

Gennova was honoured by the visit of Padma Vibhushan Prof. Ram Mashelkar, former Director General of Council of Scientific and Industrial Research (CSIR) and Director of National Chemical Laboratory (NCL); Fellow of the Royal Society (FRS), London, Foreign associate of US National Academy of Engineering and the US National Academy of Sciences.

Dr. Sanjay Singh receives the “DBT-Biotech Product, Process Development and Commercialization award 2019 (under Organization category)” for the development of Tenectase, a 3^rdgeneration thrombolytic glycoprotein for acute ischemic stroke (AIS) from Honourable Minister of Railways and Minister of Commerce and Industry – Shri Piyush Goyal.

Gennova team with the “DBT-Biotech Product, Process Development and Commercialization award 2019″

VFC Inauguration

Gennova has the state of the art Research and Development (R&D) facility – ‘Gennova Vaccine Formulation Centre and Research Laboratory’ which is recognized by Department of Scientific and Industrial Research (DSIR) with lab space of over 44,000 sq. ft..

It was inaugurated on 31^st January, 2012 by Padma Bhushan (late) Dr. M.K. Bhan, then Secretary, Department of Biotechnology, Government of India.

The inauguration of ‘Gennova Vaccine Formulation Centre and Research Laboratory’ was featured in the Nature, with objective to strengthening Industry and Academia partnership in vaccine and adjuvant development.

Gennova expands its R&D to a new building – the Vaccine Formulation Centre (VFC) spread over 40,000 sq. ft. (first and second floor) inclusive of a GMP formulation, fill and finish facility for vaccine adjuvants and biologics.

Dr. Sanjay Singh, CEO of Gennova greeting Padma Bhushan (late) Dr. M.K. Bhan, then Secretary, Department of Biotechnology, Government of India for the inauguration ceremony of Gennova’s augmented R&D – the Vaccine Formulation Centre (VFC).

Various national and international scientists and dignitaries gracing the occasion of inauguration of VFC.

Padma Bhushan (late) Dr. M.K. Bhan, formally inaugurating VFC on 31^st January 2012. He is surrounded by Dr. Ashley Birkett – Director of PATH-MVI on his right and on his left are Prof. T. S. Rao – former Senior Adviser in the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India, Padma Bhushan Dr. N. K. Ganguly – the then Director General Indian Council of Medical Research (ICMR), Dr. V P Kamboj – ex-director Central Drug Research Institute (CDRI), Prof. V. K. Chaudhary – Head, Department of Biochemistry, University of Delhi, Dr. Sanjay Singh – CEO, Gennova Biopharmaceuticals. Ltd. and Dr. Steven G Reed – the then President & CEO of Infectious Disease Research Institute, USA.

Mr. Satish Mehta, Chairman of Gennova, greeting Padma Bhushan (late) Dr. M.K. Bhan.

Dr. Sanjay Singh taking various dignitaries on a tour of VFC on the day of inauguration.

Dr. M.K. Mishra, Sr. VP – manufacturing, Gennova (standing), along with (late) Prof. K K Tewari, then board member of Gennova and Padma Shri Dr. G.C. Mishra, then Director of National Centre for Cell Science (N.C.C.S) Pune and current board member of Gennova.

9-1-Innaugration-Images-For-Gallery-Section-2

Eminent scientists and dignitaries gathered from all over the world for inauguration of VFC on 31^st January 2012.

9-1-Innaugration-Images-For-Gallery-Section-1

Eminent scientists and Gennova team members on the day of inauguration.

Padma Bhushan (late) Dr. M.K Bhan lighting the lamp, under the watchful eyes of Dr. Jaideep Moitra, VP R&D, Gennova, to commence the convention associated with the inauguration of VFC.

Students, scientists and members of Gennova participating in the convention on the day of VFC inauguration.

Mr. Satish Mehta (top left), Dr. Sanjay Singh (top right) and Padma Bhushan (late) Dr. M.K. Bhan (bottom left) addressing the gathering in the convention on the day of inauguration.